Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong
· Delayed Price · Currency is HKD 1.220
-0.010 (-0.81%)
Mar 18, 2025, 2:27 PM HKT
HKG:2348 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 1,079 | 1,151 | 1,278 | 1,165 | 1,024 | 950.01 | Upgrade
|
| Revenue Growth (YoY) | -17.29% | -9.90% | 9.66% | 13.75% | 7.82% | 0.11% | Upgrade
|
| Cost of Revenue | 493.89 | 522.67 | 511 | 489.79 | 478.72 | 427.25 | Upgrade
|
| Gross Profit | 584.78 | 628.48 | 766.68 | 675.36 | 545.55 | 522.75 | Upgrade
|
| Selling, General & Admin | 255.14 | 260.26 | 264.79 | 226.44 | 163.8 | 181.9 | Upgrade
|
| Research & Development | 103.93 | 90.81 | 79.48 | 67.03 | 57.94 | - | Upgrade
|
| Other Operating Expenses | -3.31 | 1.43 | 3.31 | 1.13 | 3.32 | 50.5 | Upgrade
|
| Operating Expenses | 355.75 | 352.49 | 347.58 | 294.6 | 225.06 | 232.4 | Upgrade
|
| Operating Income | 229.03 | 275.99 | 419.1 | 380.76 | 320.5 | 290.36 | Upgrade
|
| Interest Expense | -3.32 | -0.99 | -0.37 | -0.64 | -4.83 | -5.31 | Upgrade
|
| Interest & Investment Income | 31.63 | 26.55 | 19.85 | 20.23 | 17.46 | 17.53 | Upgrade
|
| Earnings From Equity Investments | -24.33 | -40.93 | -61.91 | -46.42 | -18.77 | -11.83 | Upgrade
|
| Currency Exchange Gain (Loss) | -2.01 | -5.53 | -4.54 | 1 | -1.48 | 2.3 | Upgrade
|
| Other Non Operating Income (Expenses) | 119.9 | 153.54 | 20.21 | 9.72 | 20.97 | 28.25 | Upgrade
|
| EBT Excluding Unusual Items | 350.9 | 408.64 | 392.36 | 364.65 | 333.85 | 321.29 | Upgrade
|
| Gain (Loss) on Sale of Investments | 292.96 | 5.68 | 7.2 | 5.56 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.26 | -0.26 | 38.84 | 69.11 | -0.46 | -0.66 | Upgrade
|
| Asset Writedown | - | - | - | - | -2.09 | -6.54 | Upgrade
|
| Other Unusual Items | - | - | 0.01 | - | - | - | Upgrade
|
| Pretax Income | 643.6 | 414.06 | 438.41 | 439.32 | 331.3 | 314.09 | Upgrade
|
| Income Tax Expense | 83.52 | 91.39 | 82.56 | 85.16 | 66.51 | 58.74 | Upgrade
|
| Earnings From Continuing Operations | 560.08 | 322.67 | 355.85 | 354.16 | 264.79 | 255.36 | Upgrade
|
| Minority Interest in Earnings | 3.03 | 3.33 | 2.21 | 4.01 | 3.34 | 0.07 | Upgrade
|
| Net Income | 563.11 | 326 | 358.06 | 358.18 | 268.13 | 255.43 | Upgrade
|
| Net Income to Common | 563.11 | 326 | 358.06 | 358.18 | 268.13 | 255.43 | Upgrade
|
| Net Income Growth | 27.30% | -8.95% | -0.03% | 33.58% | 4.97% | -15.97% | Upgrade
|
| Shares Outstanding (Basic) | 1,500 | 1,500 | 1,499 | 1,498 | 1,545 | 1,575 | Upgrade
|
| Shares Outstanding (Diluted) | 1,502 | 1,503 | 1,502 | 1,508 | 1,546 | 1,575 | Upgrade
|
| Shares Change (YoY) | -0.07% | 0.02% | -0.37% | -2.44% | -1.89% | -0.69% | Upgrade
|
| EPS (Basic) | 0.38 | 0.22 | 0.24 | 0.24 | 0.17 | 0.16 | Upgrade
|
| EPS (Diluted) | 0.37 | 0.22 | 0.24 | 0.24 | 0.17 | 0.16 | Upgrade
|
| EPS Growth | 27.45% | -8.94% | 0.34% | 36.89% | 7.03% | -15.40% | Upgrade
|
| Free Cash Flow | 156.47 | 138.85 | 229.9 | 80.07 | 163.8 | 242.02 | Upgrade
|
| Free Cash Flow Per Share | 0.10 | 0.09 | 0.15 | 0.05 | 0.11 | 0.15 | Upgrade
|
| Dividend Per Share | 0.073 | 0.073 | 0.078 | 0.065 | 0.055 | 0.052 | Upgrade
|
| Dividend Growth | -7.89% | -6.71% | 19.44% | 19.08% | 5.56% | -21.28% | Upgrade
|
| Gross Margin | 54.21% | 54.60% | 60.01% | 57.96% | 53.26% | 55.03% | Upgrade
|
| Operating Margin | 21.23% | 23.98% | 32.80% | 32.68% | 31.29% | 30.56% | Upgrade
|
| Profit Margin | 52.20% | 28.32% | 28.02% | 30.74% | 26.18% | 26.89% | Upgrade
|
| Free Cash Flow Margin | 14.51% | 12.06% | 17.99% | 6.87% | 15.99% | 25.48% | Upgrade
|
| EBITDA | 313.12 | 354.43 | 480.06 | 433.89 | 373.09 | 341.59 | Upgrade
|
| EBITDA Margin | 29.03% | 30.79% | 37.57% | 37.24% | 36.43% | 35.96% | Upgrade
|
| D&A For EBITDA | 84.09 | 78.44 | 60.96 | 53.13 | 52.6 | 51.23 | Upgrade
|
| EBIT | 229.03 | 275.99 | 419.1 | 380.76 | 320.5 | 290.36 | Upgrade
|
| EBIT Margin | 21.23% | 23.98% | 32.80% | 32.68% | 31.29% | 30.56% | Upgrade
|
| Effective Tax Rate | 12.98% | 22.07% | 18.83% | 19.38% | 20.07% | 18.70% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.